ARCT | Arcturus Therapeutics Holdings Inc
Category: Consumer goods
Quick infos Headquarters: California, United States Trade prices Volume: Market Cap: 532.78M Prev closed: Open: 20.68 High: 23.88 Low: 20.37 52 week low: 16.93 52 week high: 65 Dividends: Next ER: May 9, 2022 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast August 8, 2022 May 9, 2022 -1.94 / -1.445.24M / 6.3MFebruary 28, 2022 -1.47 / -1.725.8M / 14.72MNovember 8, 2021 -2.05 / -1.592.44M / 21.76MAugust 9, 2021 -2.07 / -2.152M / 2.32Mview more
Historical Data Date Price Open High Low Vol Change ER Jun 14, 2022 12.90 13.30 14.00
12.35
671.19K -2.2% Jun 13, 2022 13.19 14.14 14.32
12.50
1.26M -12.48% Jun 10, 2022 15.07 16.56 16.79
14.69
596.97K -12.03% Jun 9, 2022 17.13 19.20 19.20
17.03
475.67K -12.02% Jun 8, 2022 19.47 19.52 20.27
19.25
414.58K -0.36% Jun 7, 2022 19.54 18.15 19.64
18.15
605.31K 5.56% Jun 6, 2022 18.51 20.49 20.62
17.64
516.62K -7.36% Jun 3, 2022 19.98 18.44 20.00
18.30
678.78K 6.28% Jun 2, 2022 18.80 18.30 19.18
18.12
580.48K 2.23% Jun 1, 2022 18.39 20.02 20.68
18.00
516.46K -7.49% view more
NASDAQ - Nasdaq Stock Market
News
Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress finance.yahoo.com May 12, 2022 4:00 pm
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress finance.yahoo.com May 12, 2022 4:00 pm
CORRECTING and REPLACING GRAPHIC Arcturus Reports Strong Three-Month Durability Results from ARCT-154 Booster Trial finance.yahoo.com May 12, 2022 9:02 am 5 Top Stock Gainers for Thursday Amid Central Bank Policy Calls thestreet.com May 12, 2022 8:31 am
Need To Know: The Consensus Just Cut Its Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Estimates For 2022 finance.yahoo.com May 11, 2022 6:19 am
When Will Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Breakeven? finance.yahoo.com May 1, 2022 9:51 am
Arcturus' COVID-19 Vaccine Candidate Meets Primary Goal In Vietnam Study finance.yahoo.com Apr 20, 2022 11:13 am
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Mar 18, 2022 8:00 pm
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress finance.yahoo.com Mar 18, 2022 4:00 pm
Does Arcturus Therapeutics Holdings (NASDAQ:ARCT) Have A Healthy Balance Sheet? finance.yahoo.com Mar 17, 2022 6:19 am Could Arcturus Therapeutics Be the Next Moderna? fool.com Mar 1, 2022 11:00 am
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates finance.yahoo.com Feb 28, 2022 5:15 pm
Alimera Sciences (ALIM) Reports Q4 Loss, Misses Revenue Estimates finance.yahoo.com Feb 24, 2022 9:25 am
Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for finance.yahoo.com Feb 21, 2022 3:00 pm
Krystal Biotech Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand Sutherland, MD, MPH to its Board of Directors finance.yahoo.com Jan 18, 2022 7:00 am
Orbimed Advisors Llc Buys Adagio Therapeutics Inc, Zimmer Biomet Holdings Inc, Biogen Inc, ... finance.yahoo.com Dec 24, 2021 12:38 am
Arcturus Therapeutics Updates Data from ARCT-154 and ARCT-165 Booster Clinical Trial Demonstrating Robust Neutralizing Antibody Responses to SARS-CoV-2 and Several Variants finance.yahoo.com May 12, 2022 8:00 am
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern finance.yahoo.com May 12, 2022 7:00 am
Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit finance.yahoo.com Mar 25, 2022 9:49 am
Arcturus Therapeutics to Participate in the Barclays Global Healthcare Conference finance.yahoo.com Mar 14, 2022 8:00 am Key Persons CEO : Joseph E. Payne (31 May 2018–) CFO : Andrew H. Sassine Talk about Arcturus Therapeutics Holdings Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
arcturustherapeuticsinc.gcs-web.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 60 HOLD 20 SELL 20
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!